Making history is not easy. After discovering insulin 100 years ago, Frederick Banting and Charles Best spent tireless nights isolating and purifying it to treat type 1 diabetes (T1D). Their […]
History was made again
Exciting new JDRF partnership has been announced to develop an implantable islet therapy to treat type 1 diabetes
A significant part of JDRF’s research strategy is funding innovative therapies that can lead to treatment for type 1 diabetes (T1D) and eventually a cure. As part of this it […]
Canadian Tire is helping to make Canadian history again
Beginning April 4th, 2022, to honour 100 years since Leonard Thompson received the first successful insulin, injection five volunteers will brave the elements and live atop a 40-foot flagpole for […]
Dexcom is part of making history again
Approximately 300,000 Canadians live with type 1 diabetes (T1D), an autoimmune disease that destroys the cells in the pancreas responsible for making insulin. The discovery of the insulin hormone over […]
Cadillac Fairview helps to make history again
Approximately 300,000 Canadians live with type 1 diabetes (T1D), an autoimmune disease that destroys the cells in the pancreas responsible for making insulin. The discovery of the insulin hormone over […]
International Women’s Day 2022
Tuesday, March 8, 2022 marks International Women’s Day (IWD) around the word. For this year, the theme is #BreakTheBias. The theme challenges us to imagine a gender equal world, that […]
Brain Canada and JDRF fund three innovative research projects to address mental health concerns in type 1 diabetes
Last summer, Brain Canada and JDRF officially launched the JDRF Canada – Brain Canada Addressing Mental Health in Type 1 Diabetes Team Grants, a unique program that supports research on […]
In her own words
Christine MacGibbon: University Student, Former Dancer & Model Diagnosed: 9 years old Christine’s journey as a T1D warrior began 24 years ago. This was a pivotal moment for her and […]
Exciting news: new Health Canada approved clinical trials
Health Canada has approved clinical trials that could lead the way for cell replacement therapy that does not require immune suppression in people with type 1 diabetes. JDRF is the […]
JDRF-CIHR Partnership to Defeat Diabetes Grants Now Announced
The pace of type 1 diabetes (T1D) research is moving faster than ever before. In November 2021 to mark November’s National Diabetes Awareness Month, JDRF announced a new investment of $7 million to support four Canadian research […]
Access for All moves out east
Since the #AccessforAll campaign launched in 2019, we have seen considerable success with five provinces and one territory introducing new coverage for Continuous Glucose Monitors (CGM) and Flash Glucose Monitors […]
Participating in clinical trials may change the course of type one diabetes
January 23, 2022 is the 100th anniversary of the first successful insulin injection for diabetes in a human. Prior to this, a diagnosis of type 1 diabetes (T1D) meant certain […]
